

	 
       Immunocompromised patients are the most likely to gain from enhanced bactericidal activity possibly offered by lactamaminoglycoside combination therapy 9 In a comparison of lactam monotherapy with lactamaminoglycoside combination therapy restricted to patients with neutropenia we found no advantage to combination treatment 89 Although the approach to the management of patients with and without neutropenia is separated in clinical practice this similarity supports a biological basis underlying our results   At once Rob saw through the whole plot to kill him and thus secure possession of his electrical devices  
     
    
